• Evolution of PBM's

  • 2024/08/20
  • 再生時間: 45 分
  • ポッドキャスト

  • サマリー

  • In this episode, we explore the evolution and future of the Pharmacy Benefit Management (PBM) industry with insights from two seasoned pharma managed care executives. We discuss the early role of PBMs, their acquisition by pharmaceutical companies, and subsequent industry consolidation. We examine how vertical integration of the PBMs transformed their business model, including the restricted formularies that gave rise to rebates. We also address evolving PBM-manufacturer relationships, the effects of public scrutiny, and predictions for key trends. Join us for a comprehensive look at the past, present, and future of PBMs, focusing on the changes needed to better serve patients.

    Steve Stefano, Managing Director, ReprizioRx

    Steve.Stefano@repriziorx.com

    Bill Leonard, Managing Director, ReprizioRX

    wjl@repriziorx.com

    ReprizioRX

    PBMs

    IPA model HMO

    Medco

    Metro Containment Services

    Medicare Catastrophic Coverage Act of 1988

    Merck

    SmithKline Beecham

    Eli Lilly

    340B

    NDC blocks

    Group Purchasing Organizations (GPOs)

    Medicare

    United Healthcare

    FTC

    CostPlusDrugs


    Questions or comments?
    Email us at comments@prescriptionforbetteraccess.com.
    Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.

    続きを読む 一部表示

あらすじ・解説

In this episode, we explore the evolution and future of the Pharmacy Benefit Management (PBM) industry with insights from two seasoned pharma managed care executives. We discuss the early role of PBMs, their acquisition by pharmaceutical companies, and subsequent industry consolidation. We examine how vertical integration of the PBMs transformed their business model, including the restricted formularies that gave rise to rebates. We also address evolving PBM-manufacturer relationships, the effects of public scrutiny, and predictions for key trends. Join us for a comprehensive look at the past, present, and future of PBMs, focusing on the changes needed to better serve patients.

Steve Stefano, Managing Director, ReprizioRx

Steve.Stefano@repriziorx.com

Bill Leonard, Managing Director, ReprizioRX

wjl@repriziorx.com

ReprizioRX

PBMs

IPA model HMO

Medco

Metro Containment Services

Medicare Catastrophic Coverage Act of 1988

Merck

SmithKline Beecham

Eli Lilly

340B

NDC blocks

Group Purchasing Organizations (GPOs)

Medicare

United Healthcare

FTC

CostPlusDrugs


Questions or comments?
Email us at comments@prescriptionforbetteraccess.com.
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.

Evolution of PBM'sに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。